A novel quantitative computer-assisted drug-induced liver injury causality assessment tool (DILI-CAT)

We hypothesized that a drug's clinical signature (or phenotype) of liver injury can be assessed and used to quantitatively develop a computer-assisted DILI causality assessment-tool (DILI-CAT). Therefore, we evaluated drug-specific DILI-phenotypes for amoxicillin-clavulanate (AMX/CLA), cefazoli...

Ausführliche Beschreibung